Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children.
D015526:AIDS Dementia Complex / Q000097:blood / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D018932:Chemokine CCL2 / Q000097:blood / Q000134:cerebrospinal fluid; D018946:Chemokine CCL5 / Q000134:cerebrospinal fluid; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007223:Infant; D018836:Inflammation Mediators / Q000097:blood* / Q000134:cerebrospinal fluid*; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000032:analysis / Q000097:blood / Q000134:cerebrospinal fluid; D011336:Probability; D011379:Prognosis; D012367:RNA, Viral / Q000032:analysis; D012016:Reference Values; D012680:Sensitivity and Specificity; D018709:Statistics, Nonparametric; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D019562:Viral Load; D014779:Virus Replication / Q000187:drug effects
D019380:Anti-HIV Agents; D018932:Chemokine CCL2; D018946:Chemokine CCL5; D018836:Inflammation Mediators; D012367:RNA, Viral; D014409:Tumor Necrosis Factor-alpha; D020780:Matrix Metalloproteinase 9